Misleading clinical evidence and systematic reviews on ivermectin for COVID-19.

Garegnani, Luis Ignacio; Madrid, Eva; Meza, Nicolás

Garegnani, Luis Ignacio; Madrid, Eva; Meza, Nicolás.

Garegnani LI; Research Department. Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Madrid E; Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile.
Meza N; Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile nicolas.meza@uv.cl.

BMJ Evid Based Med ; 27(3): 156-158, 2022 06.

Article in English | MEDLINE | ID: covidwho-1199788

Subject(s)

COVID-19; Humans; Ivermectin/therapeutic use; SARS-CoV-2

Keywords

COVID-19; infectious disease medicine; prescription drugs; quality of health care

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: BMJ Evid Based Med Year: 2022 Document Type: Article Affiliation country: Bmjebm-2021-111678

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google